Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephritis, Interstitial | 4 | 2022 | 59 | 1.480 |
Why?
|
| Acute Kidney Injury | 4 | 2020 | 760 | 1.200 |
Why?
|
| Carrier State | 5 | 2020 | 85 | 1.120 |
Why?
|
| Agricultural Workers' Diseases | 3 | 2020 | 16 | 0.920 |
Why?
|
| Nicaragua | 6 | 2024 | 27 | 0.910 |
Why?
|
| Dengue | 2 | 2024 | 114 | 0.880 |
Why?
|
| Travel | 2 | 2024 | 202 | 0.860 |
Why?
|
| Dengue Virus | 1 | 2024 | 129 | 0.850 |
Why?
|
| RNA, Viral | 2 | 2024 | 727 | 0.790 |
Why?
|
| Staphylococcus aureus | 5 | 2020 | 560 | 0.740 |
Why?
|
| Nickel | 1 | 2020 | 45 | 0.730 |
Why?
|
| Trace Elements | 1 | 2020 | 35 | 0.730 |
Why?
|
| Staphylococcal Infections | 5 | 2020 | 679 | 0.720 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2022 | 751 | 0.570 |
Why?
|
| Nasal Cavity | 1 | 2017 | 154 | 0.520 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 290 | 0.450 |
Why?
|
| Dog Diseases | 3 | 2022 | 76 | 0.430 |
Why?
|
| Kidney | 1 | 2017 | 2119 | 0.320 |
Why?
|
| HIV Infections | 2 | 2017 | 2154 | 0.290 |
Why?
|
| Glomerular Filtration Rate | 2 | 2020 | 592 | 0.270 |
Why?
|
| Nose | 2 | 2017 | 141 | 0.250 |
Why?
|
| Cat Diseases | 2 | 2021 | 17 | 0.240 |
Why?
|
| Public Health | 3 | 2021 | 296 | 0.240 |
Why?
|
| Serogroup | 1 | 2024 | 59 | 0.230 |
Why?
|
| Disease Transmission, Infectious | 2 | 2021 | 99 | 0.220 |
Why?
|
| Young Adult | 8 | 2021 | 22201 | 0.220 |
Why?
|
| Houseflies | 1 | 2022 | 4 | 0.210 |
Why?
|
| Muscidae | 1 | 2022 | 2 | 0.210 |
Why?
|
| Cockroaches | 1 | 2022 | 7 | 0.210 |
Why?
|
| Immunoglobulin M | 1 | 2024 | 359 | 0.210 |
Why?
|
| Disease Reservoirs | 1 | 2021 | 40 | 0.200 |
Why?
|
| Sports Medicine | 1 | 2021 | 30 | 0.190 |
Why?
|
| Football | 1 | 2021 | 30 | 0.190 |
Why?
|
| Pets | 1 | 2021 | 16 | 0.190 |
Why?
|
| Education, Graduate | 1 | 2011 | 22 | 0.190 |
Why?
|
| Contact Tracing | 1 | 2021 | 62 | 0.190 |
Why?
|
| Students, Public Health | 1 | 2010 | 4 | 0.190 |
Why?
|
| Farmers | 1 | 2020 | 12 | 0.190 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2010 | 27 | 0.180 |
Why?
|
| Risk Management | 1 | 2021 | 112 | 0.180 |
Why?
|
| Nails | 1 | 2020 | 36 | 0.180 |
Why?
|
| Disaster Planning | 1 | 2011 | 69 | 0.180 |
Why?
|
| Endemic Diseases | 1 | 2020 | 69 | 0.180 |
Why?
|
| Universities | 1 | 2021 | 159 | 0.180 |
Why?
|
| Botswana | 2 | 2017 | 80 | 0.180 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 310 | 0.170 |
Why?
|
| Infection Control | 1 | 2021 | 276 | 0.170 |
Why?
|
| Communicable Disease Control | 1 | 2010 | 175 | 0.160 |
Why?
|
| Students | 1 | 2021 | 332 | 0.160 |
Why?
|
| Occupational Exposure | 1 | 2020 | 248 | 0.160 |
Why?
|
| Creatinine | 1 | 2020 | 529 | 0.160 |
Why?
|
| Arbovirus Infections | 1 | 2018 | 29 | 0.150 |
Why?
|
| Epidemiological Monitoring | 1 | 2018 | 83 | 0.150 |
Why?
|
| Risk Factors | 4 | 2018 | 17875 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 714 | 0.150 |
Why?
|
| Crowding | 1 | 2017 | 10 | 0.140 |
Why?
|
| Atrophy | 1 | 2017 | 271 | 0.140 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 707 | 0.140 |
Why?
|
| Adult | 8 | 2021 | 81946 | 0.140 |
Why?
|
| Biomarkers | 2 | 2018 | 5060 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2017 | 314 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 296 | 0.130 |
Why?
|
| Staphylococcus epidermidis | 1 | 2016 | 66 | 0.130 |
Why?
|
| Edema | 1 | 2017 | 263 | 0.130 |
Why?
|
| Dogs | 3 | 2022 | 1160 | 0.130 |
Why?
|
| Humans | 21 | 2024 | 270631 | 0.130 |
Why?
|
| Male | 12 | 2022 | 128316 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 1121 | 0.120 |
Why?
|
| Rural Population | 1 | 2017 | 292 | 0.120 |
Why?
|
| Fever | 1 | 2018 | 521 | 0.120 |
Why?
|
| Fibrosis | 1 | 2017 | 733 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2018 | 13412 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 405 | 0.110 |
Why?
|
| Incidence | 2 | 2021 | 5821 | 0.100 |
Why?
|
| Prevalence | 2 | 2017 | 3401 | 0.100 |
Why?
|
| Female | 10 | 2022 | 148865 | 0.100 |
Why?
|
| Texas | 5 | 2021 | 6436 | 0.100 |
Why?
|
| Antibodies, Viral | 1 | 2018 | 1301 | 0.100 |
Why?
|
| Cats | 2 | 2021 | 169 | 0.090 |
Why?
|
| Middle Aged | 5 | 2024 | 90294 | 0.090 |
Why?
|
| Genetic Variation | 2 | 2016 | 2165 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2020 | 6238 | 0.090 |
Why?
|
| Inflammation | 2 | 2017 | 2517 | 0.090 |
Why?
|
| Prognosis | 2 | 2018 | 22473 | 0.090 |
Why?
|
| Bacteremia | 1 | 2016 | 720 | 0.090 |
Why?
|
| Biopsy | 1 | 2017 | 3482 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 4962 | 0.080 |
Why?
|
| Leukocidins | 1 | 2008 | 45 | 0.080 |
Why?
|
| Exotoxins | 1 | 2008 | 76 | 0.080 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 229 | 0.070 |
Why?
|
| Disease Progression | 1 | 2018 | 6853 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 2348 | 0.070 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 418 | 0.070 |
Why?
|
| Community-Acquired Infections | 1 | 2008 | 286 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2018 | 6766 | 0.070 |
Why?
|
| Paraquat | 1 | 2022 | 18 | 0.050 |
Why?
|
| Agrochemicals | 1 | 2022 | 14 | 0.050 |
Why?
|
| Insect Control | 1 | 2022 | 13 | 0.050 |
Why?
|
| Cations | 1 | 2022 | 59 | 0.050 |
Why?
|
| Adolescent | 3 | 2018 | 32719 | 0.050 |
Why?
|
| Basic Reproduction Number | 1 | 2021 | 1 | 0.050 |
Why?
|
| Athletes | 1 | 2021 | 60 | 0.050 |
Why?
|
| Mutation | 1 | 2021 | 15911 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2021 | 286 | 0.050 |
Why?
|
| Surge Capacity | 1 | 2010 | 9 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2021 | 186 | 0.050 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 84 | 0.040 |
Why?
|
| United States | 3 | 2021 | 15834 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 62031 | 0.040 |
Why?
|
| Communicable Diseases, Imported | 1 | 2018 | 6 | 0.040 |
Why?
|
| Chikungunya Fever | 1 | 2018 | 24 | 0.040 |
Why?
|
| Forecasting | 1 | 2021 | 702 | 0.040 |
Why?
|
| Bites and Stings | 1 | 2018 | 44 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 518 | 0.040 |
Why?
|
| Infant | 3 | 2018 | 13982 | 0.040 |
Why?
|
| Aged | 3 | 2017 | 73338 | 0.030 |
Why?
|
| Coinfection | 1 | 2018 | 200 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 60 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2021 | 9471 | 0.030 |
Why?
|
| West Nile Fever | 1 | 2018 | 158 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 700 | 0.030 |
Why?
|
| Saccharum | 1 | 2015 | 9 | 0.030 |
Why?
|
| Sigmodontinae | 1 | 2015 | 42 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 2056 | 0.030 |
Why?
|
| Zoonoses | 1 | 2015 | 54 | 0.030 |
Why?
|
| Tropical Climate | 1 | 2015 | 50 | 0.030 |
Why?
|
| Child | 4 | 2020 | 30517 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2015 | 111 | 0.030 |
Why?
|
| Curriculum | 1 | 2011 | 916 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2021 | 1185 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2018 | 17028 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 4646 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2018 | 8694 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2015 | 331 | 0.030 |
Why?
|
| Phylogeny | 1 | 2016 | 867 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 1069 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 2495 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2015 | 208 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 4491 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 1571 | 0.030 |
Why?
|
| Exons | 1 | 2015 | 1381 | 0.020 |
Why?
|
| Pandemics | 1 | 2021 | 1607 | 0.020 |
Why?
|
| Transcriptome | 1 | 2020 | 1954 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 7097 | 0.020 |
Why?
|
| Exome | 1 | 2015 | 1248 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 4256 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2008 | 233 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 1129 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 6504 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 35586 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 30994 | 0.010 |
Why?
|